Evaluation of a Machine Learning Model Based on Pretreatment Symptoms and Electroencephalographic Features to Predict Outcomes of Antidepressant Treatment in Adults With Depression | Zendy

Pranav Rajpurkar | Zendy; Jingbo Yang | Zendy; Nathan Dass | Zendy; Vinjai Vale | Zendy; Arielle S. Keller | Zendy; Jeremy Irvin | Zendy; Zachary Taylor | Zendy; Sanjay Basu | Zendy; Andrew Y. Ng | Zendy; Leanne M. Williams | Zendy

Open Access

Evaluation of a Machine Learning Model Based on Pretreatment Symptoms and Electroencephalographic Features to Predict Outcomes of Antidepressant Treatment in Adults With Depression

Author(s) -

Pranav Rajpurkar,

Jingbo Yang,

Nathan Dass,

Vinjai Vale,

Arielle S. Keller,

Jeremy Irvin,

Zachary Taylor,

Sanjay Basu,

Andrew Y. Ng,

Leanne M. Williams

Publication year - 2020

Publication title -

jama network open

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.278

H-Index - 39

ISSN - 2574-3805

DOI - 10.1001/jamanetworkopen.2020.6653

Subject(s) - escitalopram , venlafaxine , antidepressant , major depressive disorder , sertraline , randomized controlled trial , rating scale , medicine , depression (economics) , psychiatry , psychology , mood , anxiety , developmental psychology , macroeconomics , economics

Key Points Question Can machine learning models predict improvement of various depressive symptoms with antidepressant treatment based on pretreatment symptom scores and electroencephalographic measures? Findings In this prognostic study, using the machine learning approach of gradient-boosted decision trees, the ElecTreeScore algorithm could reliably distinguish the patients who responded to treatment from those who did not based on various depressive symptoms using pretreatment symptom scores and electroencephalographic features (using the cross-validation approach on 518 patients). Meaning Machine learning approaches that include pretreatment symptom scores and electroencephalographic features may help predict which depressive symptoms will improve with antidepressants.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research